PRIMARY PERITONEAL CARCINOMA
Clinical trials for PRIMARY PERITONEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY PERITONEAL CARCINOMA trials appear
Sign up with your email to follow new studies for PRIMARY PERITONEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for Tough-to-Treat ovarian cancer
Disease control CompletedThis study tested a new drug called ZN-c3, both by itself and combined with an existing drug (niraparib), for women with advanced ovarian cancer that had stopped responding to platinum chemotherapy. The main goals were to find safe doses and see if the treatments could shrink tum…
Matched conditions: PRIMARY PERITONEAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New hope for Tough-to-Treat ovarian cancer
Disease control CompletedThis study tested a new drug called SL-172154, given alongside one of two standard chemotherapy drugs, in people with ovarian cancer that had stopped responding to platinum-based treatments. The main goals were to find a safe dose and see if the combinations showed early signs of…
Matched conditions: PRIMARY PERITONEAL CARCINOMA
Phase: PHASE1 • Sponsor: Shattuck Labs, Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Spit test trial aims to track hidden virus in cancer patients
Knowledge-focused CompletedThis study tested whether a simple saliva sample, collected at home, could be used to track cytomegalovirus (CMV) infection in people being treated for ovarian cancer. Researchers compared virus levels in saliva to standard blood tests in 49 participants. The goal was to see if r…
Matched conditions: PRIMARY PERITONEAL CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC